Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Observational Study Evaluating Effectiveness and Safety of Real-World Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A
The aim of the HEM-POWR study is to understand better how Damoctocog alfa pegol (Jivi) is used to treat people with Hemophilia A in day-to-day life, how well the treatment is tolerated and how satisfied patients and physicians are with the treatment.
Mean annualized number of reported total bleeds in patients with hemophilia A
Occurrence of AEs.
Damoctocog alfa pegol (Jivi, Bay94-9027)
Study Arms / Comparison Groups
Previously treated patient (PTPs) with hemophilia A
Description: Previously treated patients with hemophilia A receiving damoctocog alfa pegol with any kind of treatment modality (on-demand, prophylaxis, or intermittent prophylaxis)。
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
October 21, 2019
March 31, 2027
Primary Completion Date
December 31, 2026
Inclusion Criteria: - Diagnosis of hemophilia A. - Patients previously treated for Hemophilia A. - Patients without previous history of inhibitors or patients with previous history of inhibitors on standard prophylaxis therapy for at least 1 year prior to study entry. - No current evidence of FVIII inhibitor or clinical suspicion of FVIII inhibitor. - Initiation of or currently on damoctocog alfa pegol with any kind of treatment modality (on-demand, prophylaxis, or intermittent prophylaxis). - Signed informed consent/assent. Exclusion Criteria: - Concurrent participation in an investigational program with interventions outside of routine clinical practice. - Diagnosis of any other bleeding/coagulation disorder other than hemophilia A. - Contra-indications according to the local marketing authorization. - Patient on immune tolerance induction (ITI) treatment at the time of enrollment.
N/A - N/A
Accepts Healthy Volunteers
, (+)1-888-84 22937, [email protected]